NCT01976741 2021-05-06
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
Bayer
Phase 1 Completed
Clinical Trials
5 trialsNCT04675021 2021-01-26
Absolute Bioavailability and ADME Study of Savolitinib in Healthy Male Subjects
AstraZeneca
Phase 1 Completed
NCT04586491 2020-10-19
The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients
Dokuz Eylul University
Phase NA Completed
NCT03348826 2020-09-16
Study of Sodium Bicarbonate in Restoring Blocked Catheters
University Health Network, Toronto
Phase 2 Withdrawn
NCT01836328 2016-03-16
RATIOMTD
L'Hospitalet de Llobregat
Phase 3 Completed